查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1722517

不孕症藥物市場報告（按藥物類別（促性腺激素、芳香化酶抑制劑、選擇性雌激素受體調節劑、雙胍類等）、給藥途徑、配銷通路、最終用戶和地區分類，2025 年至 2033 年）

Infertility Drugs Market Report by Drug Class (Gonadotropin, Aromatase Inhibitors, Selective Estrogen Receptor Modulators, Biguanides, and Others), Route of Administration, Distribution Channel, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球不孕症藥物市場規模達 41 億美元。展望未來， IMARC Group預計到 2033 年市場規模將達到 63 億美元，2025-2033 年期間的成長率 (CAGR) 為 4.49%。不孕症的上升、輔助生殖技術（ART）的進步、政府的支持措施、醫療支出的增加、新藥的開發、保險覆蓋的可用性以及生育診所的激增都是加速市場成長的一些因素。

不孕症藥物是指各種用於治療不孕症和增強個人生殖健康的藥物。它們可以注射或口服。一些常用的不孕症藥物包括促性腺激素、芳香酶抑制劑、選擇性雌激素受體調節劑 (SERM)、雙胍類、促排卵劑、多巴胺激動劑和三環類抗憂鬱劑。它們透過刺激女性卵巢排卵和卵泡發育發揮作用，而它們有助於恢復男性睪固酮水平並提高精子品質以實現懷孕。近年來，不孕症藥物在無法懷孕的夫婦中越來越受歡迎。

不孕不孕藥物市場趨勢：

不孕症藥物透過恢復個人的受孕能力來幫助提高夫婦懷孕的機會。因此，不孕症和流產發生率的上升是推動市場成長的主要因素。除此之外，各國政府為傳播有關可用治療方案的認知而採取的多項有利舉措也刺激了對不孕症藥物的需求。此外，由於繁忙的工作日程、隨之而來的壓力和生活方式的改變，癌症、肥胖、糖尿病、甲狀腺、多囊性卵巢症候群（PCOS）和更年期障礙等慢性疾病的盛行率顯著增加。同時，由於延遲懷孕、晚婚以及酗酒、吸毒和吸煙等不良習慣導致的生育率下降正在加速產品採用率。此外，一些主要參與者正在進行研發活動，以推出療效更強、劑量要求更低、副作用更少的創新不孕症藥物。此外，用於開發這些藥物的公共資金的增加以及各監管機構加快的藥物核准速度正在推動市場成長。其他因素，包括對學名藥的需求不斷增加、醫療保健基礎設施的改善、消費者支出能力的提高、快速的城市化和技術進步，也為市場成長提供了積極的推動力。

本報告回答的關鍵問題

  • 不孕不育藥物市場有多大？不孕不育藥物市場的未來前景如何？
  • 推動不孕症藥物市場的關鍵因素有哪些？
  • 哪個地區佔據不孕症藥物最大的市場佔有率？
  • 全球不孕症藥物市場領先的公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球不孕不育藥物市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依藥品類別

  • 促性腺激素
  • 芳香化酶抑制劑
  • 選擇性雌激素受體調節劑 (SERM)
  • 雙胍類
  • 其他

第7章：市場區隔：依行政途徑

  • 口服
  • 靜脈
  • 皮下
  • 肌肉注射

第8章：市場區隔：按配銷通路

  • 醫院藥房
  • 零售藥局
  • 其他

第9章：市場區隔：依最終用戶

  • 男性
  • 女性

第10章：市場細分：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第 15 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Bayer AG
    • Ferring Pharmaceuticals
    • Livzon Pharmaceutical Group Inc.
    • Mankind Pharma
    • Merck & Co. Inc.
    • Merck KGaA
    • Novartis AG
    • Pfizer Inc.
    • Sanofi SA
    • Theramex
Product Code: SR112025A5239

The global infertility drugs market size reached USD 4.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 6.3 Billion by 2033, exhibiting a growth rate (CAGR) of 4.49% during 2025-2033. Increasing infertility rates, advancements in assisted reproductive technologies (ART), supportive government initiatives, rising healthcare expenditure, new pharmaceutical developments, availability of insurance coverage, and the proliferation of fertility clinics are some of the factors accelerating the market growth.

Infertility drugs refer to various medications used to treat infertility and enhance the reproductive health of an individual. They are either injected or taken orally. Some commonly used infertility drugs include gonadotrophins, aromatase inhibitors, selective estrogen receptor modulators (SERMs), biguanides, ovulatory stimulants, dopamine agonists, and tricyclic antidepressants. They work by stimulating ovulation and follicle development of the ovary in women, whereas they help restore testosterone levels and improve the quality of sperm in men to bring about pregnancy. In recent years, infertility drugs have gained traction among couples who are unable to conceive.

Infertility Drugs Market Trends:

Infertility drugs assist in enhancing the chances of pregnancy in couples by restoring the ability of an individual to contribute to conception. As a result, the rising incidences of infertility and miscarriage represents the primary factor driving the market growth. Besides this, several favorable initiatives undertaken by governments of various countries to spread awareness regarding the available treatment options are catalyzing the demand for infertility drugs. Additionally, there has been a significant increase in the prevalence of chronic diseases, such as cancer, obesity, diabetes, thyroid, polycystic ovarian syndrome (PCOS), and menopausal disorders, on account of hectic work schedules, accompanying stress, and lifestyle changes. Along with this, the declining fertility rates due to delayed pregnancies, late marriages, and unhealthy habits, such as excessive consumption of alcohol, drugs, and smoking, are accelerating the product adoption rates. Furthermore, several key players are engaging in research and development (R&D) activities to launch innovative infertility drugs with enhanced efficacy, lower dosage requirements, and fewer side effects. Moreover, the increasing public funding for developing these drugs and faster drug approvals from various regulatory bodies are propelling the market growth. Other factors, including the escalating demand for generic medicines, improving healthcare infrastructure, rising consumer expenditure capacities, rapid urbanization, and technological advancements, are also providing a positive thrust to the market growth.

Key Market Segmentation:

Breakup by Drug Class:

  • Gonadotropin
  • Aromatase Inhibitors
  • Selective Estrogen Receptor Modulators (SERMs)
  • Biguanides
  • Others

Breakup by Route of Administration:

  • Oral
  • Intravenous
  • Subcutaneous
  • Intramuscular

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

Breakup by End User:

  • Male
  • Female

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Bayer AG, Ferring Pharmaceuticals, Livzon Pharmaceutical Group Inc., Mankind Pharma, Merck & Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A. and Theramex.

Key Questions Answered in This Report

  • 1.How big is the infertility drugs market?
  • 2.What is the future outlook of infertility drugs market?
  • 3.What are the key factors driving the infertility drugs market?
  • 4.Which region accounts for the largest infertility drugs market share?
  • 5.Which are the leading companies in the global infertility drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Infertility Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Class

  • 6.1 Gonadotropin
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Aromatase Inhibitors
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Selective Estrogen Receptor Modulators (SERMs)
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Biguanides
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Oral
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Intravenous
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Subcutaneous
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Intramuscular
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Male
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Female
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Bayer AG
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Ferring Pharmaceuticals
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Livzon Pharmaceutical Group Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Mankind Pharma
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Merck & Co. Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Merck KGaA
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Novartis AG
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Pfizer Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Sanofi S.A.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Theramex
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Infertility Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Infertility Drugs Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Infertility Drugs Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Infertility Drugs Market: Breakup by Drug Class (in %), 2024
  • Figure 5: Global: Infertility Drugs Market: Breakup by Route of Administration (in %), 2024
  • Figure 6: Global: Infertility Drugs Market: Breakup by Distribution Channel (in %), 2024
  • Figure 7: Global: Infertility Drugs Market: Breakup by End User (in %), 2024
  • Figure 8: Global: Infertility Drugs Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Infertility Drugs (Gonadotropin) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Infertility Drugs (Gonadotropin) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Infertility Drugs (Aromatase Inhibitors) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Infertility Drugs (Aromatase Inhibitors) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Infertility Drugs (Selective Estrogen Receptor Modulators (SERMs)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Infertility Drugs (Selective Estrogen Receptor Modulators (SERMs)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Infertility Drugs (Biguanides) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Infertility Drugs (Biguanides) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Infertility Drugs (Other Drug Classes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Infertility Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Infertility Drugs (Oral) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Infertility Drugs (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Infertility Drugs (Intravenous) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Infertility Drugs (Intravenous) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Infertility Drugs (Subcutaneous) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Infertility Drugs (Subcutaneous) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Infertility Drugs (Intramuscular) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Infertility Drugs (Intramuscular) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Infertility Drugs (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Infertility Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Infertility Drugs (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Infertility Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Infertility Drugs (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Infertility Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Infertility Drugs (Male) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Infertility Drugs (Male) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Infertility Drugs (Female) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Infertility Drugs (Female) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: North America: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: North America: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: United States: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: United States: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Canada: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Canada: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Asia-Pacific: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Asia-Pacific: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: China: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: China: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Japan: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Japan: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: India: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: India: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: South Korea: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: South Korea: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Australia: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Australia: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Indonesia: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Indonesia: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Others: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Others: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Europe: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Europe: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Germany: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Germany: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: France: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: France: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: United Kingdom: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: United Kingdom: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Italy: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Italy: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Spain: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Spain: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Russia: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Russia: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Others: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Others: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Latin America: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Latin America: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Brazil: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Brazil: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Mexico: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Mexico: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Others: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Others: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Middle East and Africa: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Middle East and Africa: Infertility Drugs Market: Breakup by Country (in %), 2024
  • Figure 85: Middle East and Africa: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Global: Infertility Drugs Industry: SWOT Analysis
  • Figure 87: Global: Infertility Drugs Industry: Value Chain Analysis
  • Figure 88: Global: Infertility Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Infertility Drugs Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Infertility Drugs Market Forecast: Breakup by Drug Class (in Million USD), 2025-2033
  • Table 3: Global: Infertility Drugs Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
  • Table 4: Global: Infertility Drugs Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: Infertility Drugs Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: Infertility Drugs Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Infertility Drugs Market: Competitive Structure
  • Table 8: Global: Infertility Drugs Market: Key Players